Enfortumab Vedotin Impresses In Urothelial Cancer After Chemo, Immunotherapies

 
• By John Davis
  
Goalpost
The goal of a better therapy for urothelial cancer may be within reach. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapeutic Category